Pfizer is paying Innovent $650 million upfront to partner on cancer drug development, following Bristol Myers Squibb by ...

Continuous process improvement can benefit all aspects of life — from personal New Year’s resolutions to complex drug development. In a world where two-thirds of planned improvement initiatives fail, ...

Early-stage drug development worldwide has nearly doubled over the past decade and shifted from a U.S.-dominated model to a dual hub centered in the United States and China, according to new research ...

The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...

Apollo Therapeutics will inject capital and expertise into pipeline of potentially lifesaving medicines through an agreement with the University of Oxford. Collaboration highlights a shared strategic ...

Early-phase clinical trials are undergoing a quiet but consequential transformation. Once considered a relatively narrow checkpoint focused on basic safety and tolerability, these early-phase studies ...

The U.S. Food and Drug Administration issued a draft guidance on Wednesday to help drug developers validate alternative methods that can be used in place of animal studies during early stages of drug ...

This episode of the Pharmaron DMPK Insights Podcast Series sees Simon Taylor (Vice President of Drug Discovery at Pharmaron) and Dr. Emile Chen (former Director of Modeling and Translational Biology ...